1001 PAWTUCKET BLVD., LOWELL, MA
Earnings Release
Richard Kollender Elected as Class II Director at Annual Meeting
Rapid Micro Biosystems Enters Underwriting Agreement for 3.58M Shares
Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Changes in Board, Management or Compensation
Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance
Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
Q2
Q1
FY 2025
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Specialized Disclosure Report
Submission Upload
Correspondence